MBIA INC (MBI)

US55262C1009 - Common Stock

6.83  -0.07 (-1.01%)

After market: 6.83 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to MBI. MBI was compared to 140 industry peers in the Insurance industry. Both the profitability and financial health of MBI have multiple concerns. MBI does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

MBI had negative earnings in the past year.
In the past year MBI has reported a negative cash flow from operations.
In the past 5 years MBI always reported negative net income.
MBI had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of MBI (-23.95%) is worse than 97.10% of its industry peers.
Industry RankSector Rank
ROA -23.95%
ROE N/A
ROIC N/A
ROA(3y)-11.44%
ROA(5y)-9.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, MBI has less shares outstanding
MBI has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MBI has a worse debt to assets ratio.

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

2

3. Growth

3.1 Past

MBI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.24%.
The Revenue for MBI has decreased by -128.72% in the past year. This is quite bad
The Revenue for MBI have been decreasing by -48.40% on average. This is quite bad
EPS 1Y (TTM)3.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-128.72%
Revenue growth 3Y-72.29%
Revenue growth 5Y-48.4%
Sales Q2Q%-10%

3.2 Future

The Earnings Per Share is expected to grow by 21.68% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -11.28% on average over the next years. This is quite bad
EPS Next Y28.22%
EPS Next 2Y33.1%
EPS Next 3Y21.68%
EPS Next 5YN/A
Revenue Next Year-11.11%
Revenue Next 2Y-14.55%
Revenue Next 3Y-11.28%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MBI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MBI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as MBI's earnings are expected to grow with 21.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.1%
EPS Next 3Y21.68%

0

5. Dividend

5.1 Amount

No dividends for MBI!.
Industry RankSector Rank
Dividend Yield N/A

MBIA INC

NYSE:MBI (1/3/2025, 8:04:00 PM)

After market: 6.83 0 (0%)

6.83

-0.07 (-1.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners47.93%
Inst Owner Change-0.21%
Ins Owners11.71%
Ins Owner Change-0.09%
Market Cap348.53M
Analysts77.5
Price Target6.89 (0.88%)
Short Float %4.02%
Short Ratio3.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)97.69%
DP-76.59%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-857.1%
Min EPS beat(2)-1814.19%
Max EPS beat(2)100%
EPS beat(4)1
Avg EPS beat(4)-492.85%
Min EPS beat(4)-1814.19%
Max EPS beat(4)100%
EPS beat(8)3
Avg EPS beat(8)-476.32%
EPS beat(12)4
Avg EPS beat(12)-374.31%
EPS beat(16)5
Avg EPS beat(16)-307.77%
Revenue beat(2)2
Avg Revenue beat(2)20.23%
Min Revenue beat(2)13.15%
Max Revenue beat(2)27.3%
Revenue beat(4)4
Avg Revenue beat(4)23.76%
Min Revenue beat(4)13.15%
Max Revenue beat(4)27.3%
Revenue beat(8)8
Avg Revenue beat(8)124.53%
Revenue beat(12)12
Avg Revenue beat(12)145.78%
Revenue beat(16)15
Avg Revenue beat(16)198.93%
PT rev (1m)0%
PT rev (3m)22.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.54%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.58
EYN/A
EPS(NY)-0.81
Fwd EYN/A
FCF(TTM)-3.55
FCFYN/A
OCF(TTM)-3.55
OCFYN/A
SpS-0.53
BVpS-38.96
TBVpS-38.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.95%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-11.44%
ROA(5y)-9.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover-0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y28.22%
EPS Next 2Y33.1%
EPS Next 3Y21.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-128.72%
Revenue growth 3Y-72.29%
Revenue growth 5Y-48.4%
Sales Q2Q%-10%
Revenue Next Year-11.11%
Revenue Next 2Y-14.55%
Revenue Next 3Y-11.28%
Revenue Next 5YN/A
EBIT growth 1Y-120.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-162.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-161.99%
OCF growth 3YN/A
OCF growth 5YN/A